Menelas Pangalos

EVP, Research & Development BioPharmaceuticals

Skills and experience: Mene was appointed as Executive Vice-President, BioPharmaceuticals R&D in January 2019 and is responsible for R&D from discovery through to late-stage development for Cardiovascular, Renal & Metabolism (CVRM) and Respiratory diseases. Prior to this, he served as EVP of AstraZeneca’s Innovative Medicines and Early Development Biotech Unit and Global Business Development, where he had overall responsibility for research and early development activities spanning three continents and 2,500 people.

Roles at AstraZeneca

  • EVP, Research & Development BioPharmaceuticals

    Current role

My work style

How I prefer to work

Qualities I value in my colleagues

Sign up to see more about the team at AstraZeneca

My pet peeves

My communication style

Org chart

Direct reports

No reports


No teams